$0.1750
0.008405.04%
At close: -
$0.1732
-0.00175-1.00%
After Hours: Mar 21, 7:13 PM EDT
Comments
Loading...
Lyra Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:LYRA | Benzinga
Lyra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS
$-0.160
Quarterly Revenue
$209.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.53M
Analyze the earnings history of Lyra Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics | -$0.35 | — | — | — | $532.00K | — | — | — | 04/29/2025 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.22 | -$0.13 | -$0.16 | -23.08% | $146.00K | $204.80K | $209.00K | 2.05% | 03/13/2025 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.27 | -$0.23 | -$0.18 | 21.74% | $544.00K | $320.00K | $195.00K | -39.06% | 11/12/2024 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.36 | -$0.33 | -$0.29 | 12.12% | $458.00K | $350.00K | $598.00K | 70.86% | 08/14/2024 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.44 | -$0.26 | -$0.35 | -34.62% | $410.00K | $420.00K | $532.00K | 26.67% | 04/30/2024 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.32 | -$0.31 | -$0.22 | 29.03% | $11.00K | $390.00K | $146.00K | -62.56% | 03/21/2024 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.40 | -$0.32 | -$0.27 | 15.62% | $359.00K | $370.00K | $544.00K | 47.03% | 11/07/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.43 | -$0.42 | -$0.36 | 14.29% | $407.00K | $140.00K | $458.00K | 227.14% | 08/08/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.92 | -$0.36 | -$0.44 | -22.22% | $468.00K | $160.00K | $410.00K | 156.25% | 05/12/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$1.05 | -$0.41 | -$0.32 | 21.95% | $271.00K | $150.00K | $11.00K | -92.67% | 03/29/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.85 | -$0.44 | -$0.40 | 9.09% | $14.00K | $140.00K | $359.00K | 156.43% | 11/08/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.85 | -$0.37 | -$0.43 | -16.22% | $0.00 | $1.44M | $407.00K | -71.74% | 08/09/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.60 | -$0.91 | -$0.54 | 40.66% | $0.00 | $1.25M | $5.37M | 329.36% | 05/10/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.46 | -$0.97 | -$1.05 | -8.25% | $0.00 | — | $271.00K | — | 03/09/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.49 | -$0.73 | -$0.85 | -16.44% | $0.00 | — | $14.00K | — | 11/09/2021 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.56 | -$0.59 | -$0.85 | -44.07% | $0.00 | — | $0.00 | — | 08/09/2021 | Get Alert |
| LYRA | Lyra Therapeutics | -$18.70 | -$0.48 | -$0.60 | -25.00% | $0.00 | — | $0.00 | — | 05/11/2021 | Get Alert |
| LYRA | Lyra Therapeutics | — | -$0.56 | -$0.46 | 17.86% | — | — | $0.00 | — | 03/09/2021 | Get Alert |
| LYRA | Lyra Therapeutics | — | — | -$0.49 | — | — | — | $0.00 | — | 11/10/2020 | Get Alert |
| LYRA | Lyra Therapeutics | — | -$0.38 | -$0.56 | -47.37% | — | — | $0.00 | — | 08/05/2020 | Get Alert |
| LYRA | Lyra Therapeutics | — | — | -$18.70 | — | — | — | $0.00 | — | 05/28/2020 | Get Alert |
Lyra Therapeutics (LYRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.16 | $-0.13 | -23.1 % |
| Q3 | 2024-11-12 | $-0.18 | $-0.23 | 21.7 % |
| Q2 | 2024-08-14 | $-0.29 | $-0.33 | 12.1 % |
| Q1 | 2024-04-30 | $-0.35 | $-0.26 | -34.6 % |
Lyra Therapeutics (LYRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $209.00K | $204.80K | 2.05 % |
| Q3 | 2024-11-12 | $195.00K | $320.00K | -39.1 % |
| Q2 | 2024-08-14 | $598.00K | $350.00K | 70.9 % |
| Q1 | 2024-04-30 | $532.00K | $420.00K | 26.7 % |
FAQ
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics (LYRA) is scheduled to report earnings on April 29, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Lyra Therapeutics (NASDAQ:LYRA)?
The Actual EPS was $-0.16, which missed the estimate of $-0.13.
What were Lyra Therapeutics’s (NASDAQ:LYRA) revenues?
The Actual Revenue was $209K, which beat the estimate of $204.8K.
Browse earnings estimates, EPS, and revenue on all stocks.